Clovis Oncology Total Assets 2010-2020 | CLVS

Clovis Oncology total assets from 2010 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Clovis Oncology Annual Total Assets
(Millions of US $)
2019 $670
2018 $864
2017 $735
2016 $365
2015 $713
2014 $777
2013 $650
2012 $146
2011 $143
2010 $26
2009 $0
Clovis Oncology Quarterly Total Assets
(Millions of US $)
2020-06-30 $628
2020-03-31 $602
2019-12-31 $670
2019-09-30 $717
2019-06-30 $686
2019-03-31 $785
2018-12-31 $864
2018-09-30 $891
2018-06-30 $968
2018-03-31 $679
2017-12-31 $735
2017-09-30 $805
2017-06-30 $850
2017-03-31 $537
2016-12-31 $365
2016-09-30 $399
2016-06-30 $468
2016-03-31 $645
2015-12-31 $713
2015-09-30 $892
2015-06-30 $663
2015-03-31 $705
2014-12-31 $777
2014-09-30 $832
2014-06-30 $599
2014-03-31 $629
2013-12-31 $650
2013-09-30 $360
2013-06-30 $375
2013-03-31 $131
2012-12-31 $146
2012-09-30 $165
2012-06-30 $180
2012-03-31 $124
2011-12-31 $143
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $26
2009-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.425B $0.143B
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.912B 11.00
Amgen (AMGN) United States $140.397B 15.25
CSL (CSLLY) Australia $90.637B 0.00
Gilead Sciences (GILD) United States $85.880B 12.36
Vertex Pharmaceuticals (VRTX) United States $69.620B 38.85
Regeneron Pharmaceuticals (REGN) United States $67.394B 24.92
Illumina (ILMN) United States $51.091B 59.01
Biogen (BIIB) United States $45.824B 7.84
Seattle Genetics (SGEN) United States $27.365B 0.00
Moderna (MRNA) United States $27.286B 0.00
Genmab (GMAB) Denmark $24.126B 15.26
Alexion Pharmaceuticals (ALXN) United States $22.568B 9.40
Genmab (GNMSF) Denmark $22.519B 5.19
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.470B 0.00
BioMarin Pharmaceutical (BMRN) United States $21.428B 155.47
Incyte (INCY) United States $20.748B 0.00
BeiGene (BGNE) Cayman Islands $18.829B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.788B 0.00
BioNTech SE (BNTX) Germany $15.531B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.036B 68.01
Horizon Therapeutics Public (HZNP) Ireland $15.034B 35.18
Exact Sciences (EXAS) United States $12.814B 0.00
Sarepta Therapeutics (SRPT) United States $12.325B 0.00
Galapagos (GLPG) Belgium $12.168B 44.09
QIAGEN (QGEN) Netherlands $11.262B 28.58
ARGENX SE-ADR (ARGX) Netherlands $11.035B 0.00
Bio-Techne Corp (TECH) United States $9.977B 69.06
Immunomedics (IMMU) United States $9.246B 0.00
Novavax (NVAX) United States $8.978B 0.00
Guardant Health (GH) United States $8.497B 0.00
Repligen (RGEN) United States $7.555B 119.91
Ascendis Pharma (ASND) Denmark $7.527B 0.00
Emergent Biosolutions (EBS) United States $7.061B 27.97
Exelixis (EXEL) United States $6.792B 24.70
Vir Biotechnology (VIR) United States $6.701B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.280B 194.57
ACADIA Pharmaceuticals (ACAD) United States $6.205B 0.00
Mirati Therapeutics (MRTX) United States $6.180B 0.00
Acceleron Pharma (XLRN) United States $5.481B 0.00
Adaptive Biotechnologies (ADPT) United States $5.337B 0.00
MyoKardia (MYOK) United States $5.260B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.157B 0.00
Zai Lab (ZLAB) China $4.621B 0.00
NeoGenomics (NEO) United States $4.299B 1297.67
China Biologic Products (CBPO) China $4.253B 23.64
MorphoSys AG (MOR) Germany $4.181B 54.79
Blueprint Medicines (BPMC) United States $4.088B 0.00
Bluebird Bio (BLUE) United States $3.952B 0.00
Halozyme Therapeutics (HALO) United States $3.822B 0.00
Global Blood Therapeutics (GBT) United States $3.776B 0.00
Amicus Therapeutics (FOLD) United States $3.727B 0.00
Arena Pharmaceuticals (ARNA) United States $3.666B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.463B 0.00
Reata Pharmaceuticals (RETA) United States $3.397B 0.00
Denali Therapeutics (DNLI) United States $3.247B 0.00
Principia Biopharma (PRNB) United States $3.013B 0.00
Sorrento Therapeutics (SRNE) United States $3.011B 0.00
Fate Therapeutics (FATE) United States $2.988B 0.00
Twist Bioscience (TWST) United States $2.961B 0.00
Alkermes (ALKS) Ireland $2.952B 61.87
Insmed (INSM) United States $2.701B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.552B 0.00
Inovio Pharmaceuticals (INO) United States $2.477B 0.00
Editas Medicine (EDIT) United States $2.174B 0.00
Mesoblast (MESO) Australia $2.088B 0.00
Seres Therapeutics (MCRB) United States $2.079B 0.00
Viela Bio (VIE) United States $1.977B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
Ligand Pharmaceuticals (LGND) United States $1.821B 61.55
UniQure (QURE) Netherlands $1.817B 0.00
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
I-Mab (IMAB) China $1.706B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.642B 0.00
Sangamo Therapeutics (SGMO) United States $1.606B 0.00
Eidos Therapeutics (EIDX) United States $1.595B 0.00
Cytokineticsorporated (CYTK) United States $1.588B 0.00
Revance Therapeutics (RVNC) United States $1.588B 0.00
Arcus Biosciences (RCUS) United States $1.543B 0.00
Zealand Pharma (ZEAL) Denmark $1.539B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.415B 0.00
Coherus BioSciences (CHRS) United States $1.363B 7.95
Zymeworks (ZYME) Canada $1.346B 0.00
Intra-Cellular Therapies (ITCI) United States $1.302B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.285B 0.00
Epizyme (EPZM) United States $1.282B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Mersana Therapeutics (MRSN) United States $1.271B 0.00
NGM Biopharmaceuticals (NGM) United States $1.191B 0.00
REGENXBIO (RGNX) United States $1.182B 0.00
Compugen (CGEN) Israel $1.177B 0.00
Alcobra (ARCT) United States $1.176B 0.00
Intellia Therapeutics (NTLA) United States $1.168B 0.00
Beam Therapeutics (BEAM) United States $1.163B 0.00
Akcea Therapeutics (AKCA) United States $1.120B 0.00
Adverum Biotechnologies (ADVM) United States $1.072B 0.00
Alector (ALEC) United States $1.066B 0.00
Arvinas (ARVN) United States $1.047B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.042B 0.00
Heska (HSKA) United States $0.999B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.965B 0.00
NantKwest (NK) United States $0.956B 0.00
Myriad Genetics (MYGN) United States $0.944B 0.00
Retrophin (RTRX) United States $0.933B 0.00
Athenex (ATNX) United States $0.911B 0.00
VBI Vaccines (VBIV) United States $0.842B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.835B 0.00
Castle Biosciences (CSTL) United States $0.813B 0.00
Pharming Group (PHGUF) Netherlands $0.801B 18.29
Morphic Holding (MORF) United States $0.799B 0.00
Codexis (CDXS) United States $0.787B 0.00
Intrexon (PGEN) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.764B 0.00
Frequency Therapeutics (FREQ) United States $0.736B 0.00
Dynavax Technologies (DVAX) United States $0.736B 0.00
Cellectis S.A (CLLS) France $0.727B 0.00
MiMedx (MDXG) United States $0.725B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.720B 0.00
Kadmon Holdings (KDMN) United States $0.707B 0.00
Vericel (VCEL) United States $0.695B 0.00
Agenus (AGEN) United States $0.681B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.638B 5.58
ZIOPHARM Oncology Inc (ZIOP) United States $0.632B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.610B 0.00
Cue Biopharma (CUE) United States $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Protagonist Therapeutics (PTGX) United States $0.578B 0.00
Syros Pharmaceuticals (SYRS) United States $0.545B 0.00
MeiraGTx Holdings (MGTX) United States $0.526B 0.00
BioDelivery Sciences (BDSI) United States $0.518B 36.68
Aquinox Pharmaceuticals (NLTX) United States $0.513B 0.00
Geron (GERN) United States $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.508B 22.22
Innate Pharma S.A (IPHA) France $0.501B 0.00
Prothena (PRTA) Ireland $0.492B 0.00
Kala Pharmaceuticals (KALA) United States $0.492B 0.00
Cel-Sci (CVM) United States $0.491B 0.00
Avid Bioservices (CDMO) United States $0.480B 0.00
Athersys (ATHX) United States $0.480B 0.00
UROGEN PHARMA (URGN) United States $0.480B 0.00
AC Immune SA (ACIU) Switzerland $0.463B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.463B 0.00
AnaptysBio (ANAB) United States $0.462B 0.00
Kamada (KMDA) Israel $0.443B 21.17
Pfenex (PFNX) United States $0.438B 0.00
IVERIC Bio (ISEE) United States $0.428B 0.00
Celldex Therapeutics (CLDX) United States $0.403B 0.00
Prometic Life Sciences (LMNL) Canada $0.399B 0.00
ANI Pharmaceuticals (ANIP) United States $0.399B 9.42
Scholar Rock Holding (SRRK) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.381B 0.00
Albireo Pharma (ALBO) United States $0.380B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.379B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
MannKind (MNKD) United States $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
Biofrontera AG (BFRA) Germany $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
WAVE Life Sciences (WVE) Singapore $0.332B 0.00
Precision BioSciences (DTIL) United States $0.319B 0.00
OSMOTICA PHARM (OSMT) United States $0.317B 0.00
CytomX Therapeutics (CTMX) United States $0.317B 0.00
IBio (IBIO) United States $0.308B 0.00
Trevena (TRVN) United States $0.307B 0.00
Sutro Biopharma (STRO) United States $0.306B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.302B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.297B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
Arbutus Biopharma (ABUS) United States $0.281B 0.00
Fortress Biotech (FBIO) United States $0.277B 0.00
Selecta Biosciences (SELB) United States $0.275B 0.00
Starpharma Holdings (SPHRY) Australia $0.275B 0.00
Menlo Therapeutics (MNLO) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
Spero Therapeutics (SPRO) United States $0.264B 0.00
Affimed (AFMD) Germany $0.262B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
NextCure (NXTC) United States $0.251B 0.00
Verastem (VSTM) United States $0.249B 0.00
Forte Biosciences (FBRX) United States $0.239B 0.00
Northwest Biotherapeutics (NWBO) United States $0.237B 0.00
Abeona Therapeutics (ABEO) United States $0.233B 0.00
HOOKIPA Pharma (HOOK) United States $0.222B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.215B 0.00
XOMA (XOMA) United States $0.213B 0.00
Dyadic (DYAI) United States $0.210B 0.00
Theratechnologies (THTX) Canada $0.208B 0.00
Exicure (XCUR) United States $0.201B 0.00
Strongbridge Biopharma (SBBP) United States $0.201B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Aduro Biotech (ADRO) United States $0.195B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.194B 9.05
Nymox Pharmaceutical (NYMX) Canada $0.193B 0.00
Cerecor (CERC) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Five Prime Therapeutics (FPRX) United States $0.185B 0.00
Cyclerion Therapeutics (CYCN) United States $0.176B 0.00
Aptinyx (APTX) United States $0.175B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Cidara Therapeutics (CDTX) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.156B 0.00
Bellus Health (BLU) Canada $0.153B 0.00
TELA Bio (TELA) United States $0.150B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Eton Pharmaceuticals (ETON) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Celyad SA (CYAD) Belgium $0.144B 0.00
VolitionRX (VNRX) United States $0.143B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
CorMedix Inc (CRMD) United States $0.136B 0.00
Cardiff Oncology (CRDF) United States $0.135B 0.00
Gritstone Oncology (GRTS) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.131B 0.00
Palatin Technologies (PTN) United States $0.130B 3.32
Oncobiologics (OTLK) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.125B 6.38
Lumos Pharma (LUMO) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.123B 0.00
Protalix BioTherapeutics (PLX) Israel $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Catalyst Biosciences (CBIO) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
ARAVIVE, INC (ARAV) United States $0.103B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Cocrystal Pharma (COCP) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
AquaBounty Technologies (AQB) United States $0.082B 0.00
AnPac Bio-Medical Science (ANPC) China $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 90.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
IMMURON (IMRN) Australia $0.062B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Bionano Genomics (BNGO) United States $0.059B 0.00
Soligenix (SNGX) United States $0.059B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.046B 0.00
Novogen (KZIA) Australia $0.043B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Celsion (CLSN) United States $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Cesca Therapeutics (THMO) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Chanticleer Holdings (SONN) United States $0.025B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00